Commentator views former Ørsted CEO as potential Novo Nordisk chairman
For life science companies, it's no longer enough to have experts from own industry in the board room, according to business commentator Jens Christian Hansen. He sees many advantages to Novo Nordisk's interest in including former Ørsted CEO Henrik Poulsen in the company board.
BY ULRICH QUISTGAARD, TRANSLATED BY NIELSINE NIELSEN
Read this article for free
Register with your E-mail. No credit card required.
Chair of the Novo Nordisk Board Helge Lund thinks tax payers will be paying a large bill for the Covid-19 crisis. He also expects an additional pressure to fall on the pharmaceutical industry in future years.
Denmark wishes to establish a Covid-19 research fund with Israel and Austria and explore the possibility of a joint vaccine production with the two countries, according to the parties at a press conference.